ASCIA News
-
Change to My Health Record COVID-19 Pathology Reports
8 January 2021: As part of the Australian Government’s pandemic response, a change has been made in the My Health Record system so that COVID-19 pathology reports are available to consumers in their My Health Record sooner. This change has been made in consultation with indu... -
Safety Alert: Zostavax Vaccine – NOT to be used in people with compromised immune function
23 December 2020: Professor Paul Kelly, the Chief Medical Officer of the Australian Government Department of Health, has issued the following notice regarding the Zostavax vaccine for prevention of shingles. CMO letter re Zostavax 22 Dec 2020176.56 KB Zostavax is a live, att... -
ASCIA’s Plans for 2021
21 December 2020: As the challenging year of 2020 is coming to an end, we take this opportunity to update you on ASCIA’s plans for 2021. These plans include: Updating and developing more online resources to support ASCIA members, patients/carers, other health professionals a... -
ASCIA Oral Immunotherapy (OIT) for Food Allergy Update
3 December 2020: Oral immunotherapy (OIT) is a potential treatment for food allergy. It involves giving gradually increasing amounts of food allergen under medical supervision and continued daily consumption of the food allergen. If the goal of desensitisation is reached, th... -
AIFA Research Grants 2020
1 December 2020: It is a pleasure to announce that the Allergy and Immunology Foundation of Australasia (AIFA) has awarded $110,000 in grants to five outstanding allergy and immunology research projects in 2020. To read more about the projects listed below go to www.allergyi... -
Updated ASCIA FAQ How to Introduce Solid Foods for Allergy Prevention
30 November 2020: In response to recent feedback and as part of our commitment to regularly review ASCIA online resources, updates have been made to the ASCIA Frequently Asked Questions (FAQ) How to Introduce Solid Foods for Allergy Prevention document. This is the third mos... -
ASCIA COVID-19 update
9 November 2020: In Australia and New Zealand the response to the COVID-19 pandemic has been world leading, with minimal community transmission. However, outbreaks have occurred, and work continues on prevention and treatment of COVID-19, including new vaccines. The ASCIA CO... -
ASCIA Immunodeficiency Strategy for Australia and New Zealand
6 November 2020: It is a pleasure to announce that the ASCIA Immunodeficiency Strategy for Australia and New Zealand has now been completed and is available at www.nationalimmunodeficiencystrategy.org.au Over the past two years ASCIA has worked in collaboration with patient...
-
Site updated: 8 Jan 2021
ASCIA Update
Information for the community about allergic diseases, immunodeficiencies and other immune diseases.
See latest edition here...
Join our mailing list here...
About ASCIA
ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases
Quick Links
About ASCIA
ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...
The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...
Disclaimer I Privacy
The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...
ASCIA respects your privacy. Read our privacy policy here...
Sponsors | Advertising
ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites.
The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.
Accreditiation
This site complies with the HONcode standard for trustworthy health information: verify here.